Results 111 to 120 of about 2,155,517 (183)

Is It Policy And Not Treatment That Actually Determines Epilepsy Outcomes? [PDF]

Epilepsy Curr
Ali A, McKee HR, Sisodiya SM.
europepmc   +1 more source

Gaps in disaster cost reporting and rising economic burdens in Canada, 1990-2020: retrospective database analysis. [PDF]

Lancet Reg Health Am
El-Baba M, Hertelendy AJ, Voskanyan A, Ciottone GR, Issa F.   +4 more
europepmc   +1 more source

Smoking-attributable hospitalisation costs in Europe: an econometric analysis of the European Health Interview Survey, 2019. [PDF]

BMJ Public Health
Stazi G, López-Nicolás Á, Torrado Ortega C.   +2 more
europepmc   +1 more source

Deep Learning-Enabled Diabetic Retinopathy Screening: A Techno-Clinical Revolution or Just More Artificial Intelligence Hype? [PDF]

Diabetes Care
Dave D, Steinhubl SR, McQueen RB.
europepmc   +1 more source

Measuring and valuing spillover effects in caregivers and families: A scoping review. [PDF]

PLoS One
Dang TTH, Tabinga A, Beilby H, Barker N, Johnson LR, Tuffaha H, Connelly LB, Maguire AM.   +7 more
europepmc   +1 more source

Antibiotic consumption and medication cost in diabetic patients: Insights from Iran health insurance organization (IHIO) claims data. [PDF]

PLoS One
Ghotbi AB, Khoshparast B, Hekmat H, Shahali Z, Golestani A, Tabatabaei-Malazy O.   +5 more
europepmc   +1 more source

Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms. [PDF]

PLoS One
Wambua J, Lang JC, Ogunjimi B, Hens N, Beutels P.   +4 more
europepmc   +1 more source

Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and Spain. [PDF]

Hum Vaccin Immunother
Nikitas G, Mohy A, Duchenne M, Genovez V, Casabona G, Hennessy E, Vallejo L, Haddouche AA, Marijam A.   +8 more
europepmc   +1 more source

The Financial and Workforce Impact of Medication Errors in the Finnish Public Healthcare System: A Pilot Study. [PDF]

Health Serv Insights
Kanninen JC, Ojala R, Ahonen J, Kautiainen H, Holm A, Valkonen V.   +5 more
europepmc   +1 more source

Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore. [PDF]

Ther Adv Med Oncol
Ouyang Y, Ng YT, Hong WW, Graves N.
europepmc   +1 more source